Nova Leap Health Stock Price To Earning
| NVLPF Stock | USD 0.17 0.01 5.56% |
Nova Leap Health fundamentals help investors to digest information that contributes to Nova Leap's financial success or failures. It also enables traders to predict the movement of Nova OTC Stock. The fundamental analysis module provides a way to measure Nova Leap's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Leap otc stock.
Nova |
Nova Leap Health OTC Stock Price To Earning Analysis
Nova Leap's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Nova Leap Price To Earning | 10.57 X |
Most of Nova Leap's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nova Leap Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Nova Leap Health has a Price To Earning of 10.57 times. This is 59.09% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The price to earning for all United States stocks is 63.2% higher than that of the company.
Nova Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Leap's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Nova Leap could also be used in its relative valuation, which is a method of valuing Nova Leap by comparing valuation metrics of similar companies.Nova Leap is currently under evaluation in price to earning category among its peers.
Nova Fundamentals
| Return On Equity | -0.0309 | |||
| Return On Asset | -0.0294 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 18.18 M | |||
| Shares Outstanding | 86.21 M | |||
| Shares Owned By Insiders | 36.06 % | |||
| Price To Earning | 10.57 X | |||
| Price To Book | 1.12 X | |||
| Price To Sales | 0.79 X | |||
| Revenue | 21.28 M | |||
| Gross Profit | 7.21 M | |||
| EBITDA | 3.74 M | |||
| Net Income | 1.76 M | |||
| Cash And Equivalents | 794.12 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 896.13 K | |||
| Debt To Equity | 0.33 % | |||
| Current Ratio | 0.87 X | |||
| Book Value Per Share | 0.22 X | |||
| Cash Flow From Operations | 2.18 M | |||
| Beta | 0.66 | |||
| Market Capitalization | 16.91 M | |||
| Total Asset | 26.77 M | |||
| Z Score | 10.8 | |||
| Net Asset | 26.77 M |
About Nova Leap Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Leap Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Leap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Leap Health based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Nova OTC Stock
Nova Leap financial ratios help investors to determine whether Nova OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Leap security.